Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,191
archived clinical trials in
Constipation

mi
from
Smithfield, PA
Braintree Research Site 18
mi
from
Smithfield, PA
Click here to add this to my saved trials
mi
from
Lancaster, SC
Braintree Research Site 23
mi
from
Lancaster, SC
Click here to add this to my saved trials
mi
from
Chattanooga, TN
Braintree Research Site 22
mi
from
Chattanooga, TN
Click here to add this to my saved trials
mi
from
Knoxville, TN
Braintree Research Site 31
mi
from
Knoxville, TN
Click here to add this to my saved trials
mi
from
Houston, TX
Braintree Research Site 40
mi
from
Houston, TX
Click here to add this to my saved trials
mi
from
San Antonio, TX
Braintree Research Site 34
mi
from
San Antonio, TX
Click here to add this to my saved trials
mi
from
West Jordan, UT
Braintree Research Site 42
mi
from
West Jordan, UT
Click here to add this to my saved trials
mi
from
Newport News, VA
Braintree Research Site 14
mi
from
Newport News, VA
Click here to add this to my saved trials
mi
from
Norfolk, VA
Braintree Research Site 49
mi
from
Norfolk, VA
Click here to add this to my saved trials
mi
from
Cincinnati, OH
Braintree Research Site 6
mi
from
Cincinnati, OH
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated:  12/31/1969
mi
from
Plano, TX
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Braintree Research Site 1
mi
from
Plano, TX
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated:  12/31/1969
mi
from
Corona, CA
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Braintree Research Site 29
mi
from
Corona, CA
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated:  12/31/1969
mi
from
Brandon, FL
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Braintree Research Site 13
mi
from
Brandon, FL
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated:  12/31/1969
mi
from
Hialeah, FL
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Braintree Research Site 10
mi
from
Hialeah, FL
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated:  12/31/1969
mi
from
Miami Lakes, FL
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Braintree Research Site 19
mi
from
Miami Lakes, FL
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated:  12/31/1969
mi
from
Miami, FL
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Braintree Research Site 2
mi
from
Miami, FL
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated:  12/31/1969
mi
from
Palmetto Bay, FL
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Braintree Research Site 139
mi
from
Palmetto Bay, FL
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated:  12/31/1969
mi
from
Saint Petersburg, FL
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Braintree Research Site 12
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated:  12/31/1969
mi
from
West Palm Beach, FL
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Braintree Research Site 1
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated:  12/31/1969
mi
from
Owensboro, KY
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Braintree Research Site 24
mi
from
Owensboro, KY
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated:  12/31/1969
mi
from
Lake Charles, LA
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Braintree Research Site 15
mi
from
Lake Charles, LA
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated:  12/31/1969
mi
from
Las Vegas, NV
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Braintree Research Site 24
mi
from
Las Vegas, NV
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated:  12/31/1969
mi
from
Fayetteville, NC
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Braintree Research Site 21
mi
from
Fayetteville, NC
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated:  12/31/1969
mi
from
Cincinnati, OH
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Braintree Research Site 6
mi
from
Cincinnati, OH
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated:  12/31/1969
mi
from
Chattanooga, TN
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Braintree Research Site 22
mi
from
Chattanooga, TN
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated:  12/31/1969
mi
from
Memphis, TN
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Braintree Research Site 20
mi
from
Memphis, TN
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated:  12/31/1969
mi
from
Nashville, TN
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Braintree Research Site 10
mi
from
Nashville, TN
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated:  12/31/1969
mi
from
Carrollton, TX
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Braintree Research Site 20
mi
from
Carrollton, TX
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated:  12/31/1969
mi
from
Houston, TX
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Braintree Research Site 40
mi
from
Houston, TX
Click here to add this to my saved trials
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated:  12/31/1969
mi
from
Newport News, VA
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults
Status: Enrolling
Updated: 12/31/1969
Braintree Research Site 14
mi
from
Newport News, VA
Click here to add this to my saved trials
Naloxegol for the Prevention of Constipation in Postoperative Spinal Surgery Patients
A Double-blind, Randomized, Placebo-controlled Trial of Naloxegol for Prevention of Post-operative Constipation in Spinal Surgery Patients
Status: Enrolling
Updated:  12/31/1969
mi
from
Boston, MA
Naloxegol for the Prevention of Constipation in Postoperative Spinal Surgery Patients
A Double-blind, Randomized, Placebo-controlled Trial of Naloxegol for Prevention of Post-operative Constipation in Spinal Surgery Patients
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated:  12/31/1969
mi
from
Los Angeles, CA
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Keck Hospital of the University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated:  12/31/1969
mi
from
Englewood, CO
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Rocky Mountain Movement Disorders Center
mi
from
Englewood, CO
Click here to add this to my saved trials
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated:  12/31/1969
mi
from
Boca Raton, FL
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Parkinson's Disease and Movement Disorders Center of Boca Raton
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated:  12/31/1969
mi
from
Tampa, FL
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
USF Health Byrd Parkinson's Disease Movement Disorders Center of Excellence
mi
from
Tampa, FL
Click here to add this to my saved trials
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated:  12/31/1969
mi
from
New York, NY
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Movement Disorders Division, Mt. Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated:  12/31/1969
mi
from
Cleveland, OH
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Parkinson's & Movement Disorders Center, UH Cleveland Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated:  12/31/1969
mi
from
Washington,
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Georgetown Universtiy, Department of Neurology
mi
from
Washington,
Click here to add this to my saved trials
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated:  12/31/1969
mi
from
Jacksonville, FL
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Neuroscience Research, University of Florida Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated:  12/31/1969
mi
from
Port Charlotte, FL
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
MEDSOL Clinical Research
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated:  12/31/1969
mi
from
Saint Petersburg, FL
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Suncoast Neuroscience Associates Inc
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated:  12/31/1969
mi
from
Sarasota, FL
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Sarasota Memory Hospital Clinical Research Ctr.
mi
from
Sarasota, FL
Click here to add this to my saved trials
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated:  12/31/1969
mi
from
Farmington Hills, MI
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
QUEST Research Institute
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated:  12/31/1969
mi
from
Cincinnati, OH
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Riverhills Healthcare, Inc
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated:  12/31/1969
mi
from
Hershey, PA
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Penn State Health, Department of Neurology
mi
from
Hershey, PA
Click here to add this to my saved trials
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated:  12/31/1969
mi
from
Philadelphia, PA
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
A Multi-Center, Single-Dose, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Status: Enrolling
Updated: 12/31/1969
Thomas Jefferson University, Department of Neurology
mi
from
Philadelphia, PA
Click here to add this to my saved trials
The Effect of CSP01 on Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation
A Randomized, Single Center, Double-blind, Parallel-group, Placebo-controlled Study Assessing the Effect of CSP01 on Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation
Status: Enrolling
Updated:  12/31/1969
mi
from
Boston, MA
The Effect of CSP01 on Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation
A Randomized, Single Center, Double-blind, Parallel-group, Placebo-controlled Study Assessing the Effect of CSP01 on Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
To Evaluate Patient Preference of Movantik and Polyethylene Glycol 3350 for Opioid Induced Constipation
A Phase IV, Randomized, Multi-Center, Open-Label, Prospective, Crossover Study to Evaluate Patient Preference of Movantik™ Versus Polyethylene Glycol 3350 for Opioid-Induced Constipation (OIC) Treatment
Status: Enrolling
Updated:  12/31/1969
mi
from
Lincoln, CA
To Evaluate Patient Preference of Movantik and Polyethylene Glycol 3350 for Opioid Induced Constipation
A Phase IV, Randomized, Multi-Center, Open-Label, Prospective, Crossover Study to Evaluate Patient Preference of Movantik™ Versus Polyethylene Glycol 3350 for Opioid-Induced Constipation (OIC) Treatment
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Lincoln, CA
Click here to add this to my saved trials
To Evaluate Patient Preference of Movantik and Polyethylene Glycol 3350 for Opioid Induced Constipation
A Phase IV, Randomized, Multi-Center, Open-Label, Prospective, Crossover Study to Evaluate Patient Preference of Movantik™ Versus Polyethylene Glycol 3350 for Opioid-Induced Constipation (OIC) Treatment
Status: Enrolling
Updated:  12/31/1969
mi
from
Anaheim, CA
To Evaluate Patient Preference of Movantik and Polyethylene Glycol 3350 for Opioid Induced Constipation
A Phase IV, Randomized, Multi-Center, Open-Label, Prospective, Crossover Study to Evaluate Patient Preference of Movantik™ Versus Polyethylene Glycol 3350 for Opioid-Induced Constipation (OIC) Treatment
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Anaheim, CA
Click here to add this to my saved trials
To Evaluate Patient Preference of Movantik and Polyethylene Glycol 3350 for Opioid Induced Constipation
A Phase IV, Randomized, Multi-Center, Open-Label, Prospective, Crossover Study to Evaluate Patient Preference of Movantik™ Versus Polyethylene Glycol 3350 for Opioid-Induced Constipation (OIC) Treatment
Status: Enrolling
Updated:  12/31/1969
mi
from
Los Gatos, CA
To Evaluate Patient Preference of Movantik and Polyethylene Glycol 3350 for Opioid Induced Constipation
A Phase IV, Randomized, Multi-Center, Open-Label, Prospective, Crossover Study to Evaluate Patient Preference of Movantik™ Versus Polyethylene Glycol 3350 for Opioid-Induced Constipation (OIC) Treatment
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Los Gatos, CA
Click here to add this to my saved trials